← Back to patent-cliff list
CAS 875712-88-2
(Z)-ethyl 3-((6-amino-3,5-difluoropyridin-2-yl)amino)-2-(2,4,5-trifluorobenzoyl)acrylate
Codes: DELAF-004
Application context (from source-drug indications)
Community-acquired bacterial pneumoniaDelafloxacinCommunity-acquired pneumoniaDelafloxacinBacterial skin diseaseDelafloxacinSkin and skin structure infectionDelafloxacin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Delafloxacin | Tier C — Watch / trade | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,4,5-trifluorobenzoic acid→ethyl 3-oxo-3-(2,4,5-trifluorophenyl)propanoate→3,5-difluoropyridine-2,6-diamine→(Z)-ethyl 3-((6-amino-3,5-difluoropyridin-2-yl)amino)-2-(2,4,5-trifluorobenzoyl)acrylate→azetidin-3-ol hydrochloride→ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.